MK0731

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK0731, covering 2015-01-30 to 2015-01-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MK0731 in Patients With Advanced Solid Tumors (0731-002)(COMPLETED) [Phase 1]